AREV Life Sciences Global Corp
AREVF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$15.88K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $15,881.00 |
|---|---|
| Enterprise Value | $159,524.00 |
| Earnings per Share | $-0.05 |
| Beta | 4.94 |
| Outstanding Shares | 31,762,363 |
Return
| Return on Equity | 20.59% |
|---|---|
| Return on Assets | -112.31% |
| Return on Invested Capital | 20.25% |
Valuation & Multiples
| P/E Ratio | -1.88 |
|---|---|
| PEG | 2.13 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 22.13 |
| Enterprise Value to EBIT | -0.68 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.91 |
| Debt to Equity | -0.13 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About AREV Life Sciences Global Corp
19,534 employees
CEO: Michael C. Withrow
AREV Life Sciences Global Corp. operates as an early-stage life science discovery company in Canada. It is involved in the extraction of compounds for consumption and topical use; clinical nutrition business; and Medicine Merchant, a tec...